Is there any difference in RA patients for methotrexate use vs leflunomide use as a concomitant treatment with biological and targeted synthetic DMARDS in TURKBİO Registry?

Creative Commons License

İNANÇ G. N., ÖZEN G., YALÇINKAYA Y., DALKILIÇ H. E., KOCA S. S., CAN G., ...Daha Fazla

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.611, (Tam Metin Bildiri) identifier